Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
18°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Biogen Inc
Recent news which mentions Biogen Inc
< Previous
1
2
3
Next >
Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
October 30, 2024
Tags
Breaking news
Companies
Business
From
CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
October 29, 2024
Tags
DR Horton Inc
Microsoft Corp
Biogen Inc
From
CNBC.com News
5 things to know before the stock market opens Monday
October 28, 2024
Tags
Peloton Interactive Inc
Politics
Intel Corp
From
CNBC.com News
Thursday's big stock stories: What's likely to move the market in the next trading session
September 25, 2024
Tags
WABTEC CORP DRN
Pentair PLC
Biogen Inc
From
CNBC.com News
5 things to know before the stock market opens Monday
September 09, 2024
Tags
Economy
Eisai Co Ltd
Business News
From
CNBC.com News
Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
September 08, 2024
Tags
US: News
Pharmaceuticals
Health & Science
From
CNBC.com News
Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
August 01, 2024
Tags
Breaking News: Business
Business News
Biotech and Pharmaceuticals
From
CNBC.com News
Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says
July 30, 2024
Tags
Biotech and Pharmaceuticals
Biotechnology
Breaking News: Business
From
CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
July 30, 2024
Tags
Science
Business News
Eisai Co Ltd
From
CNBC.com News
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
July 26, 2024
Tags
Eisai Co Ltd
Business News
Science
From
CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
June 11, 2024
Tags
Eisai Co Ltd
Business News
Biogen Inc
From
CNBC.com News
Cramer's Lightning Round: Bank of America is a buy
May 10, 2024
Tags
Chevron Corp
U/S/ Markets
S&P 500
From
CNBC.com News
Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up
April 24, 2024
Tags
Biogen Inc
Business
Health care industry
From
CNBC.com News
5 things to know before the stock market opens Monday
April 22, 2024
Tags
NVIDIA Corp
Business News
Meta Platforms Inc
From
CNBC.com News
Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move
March 08, 2024
Tags
Business
Biogen Inc
Health care industry
From
CNBC.com News
Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start
February 20, 2024
Tags
Biogen Inc
Health & Science
Health care industry
From
CNBC.com News
Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
February 13, 2024
Tags
Eisai Co Ltd
Business News
Biotechnology
From
CNBC.com News
5 things to know before the stock market opens Monday
February 12, 2024
Tags
Anheuser/Busch Inbev SA
Business News
Lyft Inc
From
CNBC.com News
Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
January 31, 2024
Tags
Business
Biogen Inc
Health care industry
From
CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
December 20, 2023
Tags
Amgen Inc
Pharmaceuticals
Health & Science
From
CNBC.com News
5 things to know before the stock market opens Monday
November 06, 2023
Tags
Lyft Inc
Business News
Economy
From
CNBC.com News
More convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in study
October 25, 2023
Tags
Health & Science
Pharmaceuticals
US: News
From
CNBC.com News
Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drug
August 07, 2023
Tags
US: News
Drug approvals
Regulations
From
CNBC.com News
Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more
July 28, 2023
Tags
stocks
AstraZeneca PLC
Mondelez International Inc
From
CNBC.com News
Stocks making the biggest moves midday: Spotify, RTX, General Electric and more
July 25, 2023
Tags
Finance
Alaska Air Group Inc
Raytheon Technologies Corp
From
CNBC.com News
Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
July 25, 2023
Tags
US: News
Business News
Wells Fargo & Co
From
CNBC.com News
5 things to know before the stock market opens Tuesday
July 18, 2023
Tags
Morgan Stanley
Tesla Inc
Eli Lilly and Co
From
CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
July 17, 2023
Tags
Biogen Inc
Business
Health care industry
From
CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
July 08, 2023
Tags
Breaking News: Business
Eisai Co Ltd
Science
From
CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
July 07, 2023
Tags
Companies
Biogen Inc
Business
From
CNBC.com News
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.